U.S. Healthcare Services Stock News

NYSE:AON
NYSE:AONInsurance

Has Aon (AON) Share Weakness Opened A Valuation Opportunity For Investors

Wondering whether Aon’s current share price still reflects good value, or if most of the opportunity has already been priced in? This article looks at the stock through a clear valuation lens so you can frame your own view. Aon’s share price closed at US$310.90, with returns of 0.9% over the past week, a decline of 4.5% over the past month, a decline of 9.7% year to date and a decline of 10.9% over the past year. These figures may change how investors think about its risk and return trade...
NasdaqGM:LGND
NasdaqGM:LGNDPharmaceuticals

A Look At Ligand Pharmaceuticals (LGND) Valuation After XOMA Deal And Viking TR Beta Licensing Dispute

Ligand Pharmaceuticals (LGND) is back in focus after its latest quarterly update, which combined higher royalty revenues and adjusted EPS with the planned XOMA acquisition and a contested termination of the Viking TR Beta licensing program. See our latest analysis for Ligand Pharmaceuticals. The stock has eased in the very short term, with a 7 day share price return of down 4.9%. However, the 90 day share price return of 21.8% and the 1 year total shareholder return of 110.5% point to strong...
NYSE:VMI
NYSE:VMIConstruction

How Investors May Respond To Valmont Industries (VMI) Profitability Gains And Positive Analyst Sentiment

In recent months, Valmont Industries has reported strong earnings per share growth and a wider free cash flow margin, while analysts and brokers have maintained favorable rankings and recommendations based on its fundamentals. This combination of rising profitability metrics and broadly positive analyst sentiment has reinforced the view that Valmont’s operational improvements are materially strengthening its underlying business quality. With this backdrop of improving profitability and...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Royalty Pharma (RPRX) Valuation Check After Strong Q1 Earnings And Rising Investor Interest

Royalty Pharma earnings and buyback catch investors’ attention Royalty Pharma (RPRX) has drawn fresh investor focus after reporting first quarter 2026 earnings with revenue of US$630.58 million and net income of US$294.69 million, alongside continued progress on its multi year share repurchase program. See our latest analysis for Royalty Pharma. The stock has picked up momentum, with a 1 day share price return of 3.0% and a year to date share price return of 37.03%, while the 1 year total...
NasdaqGS:EQIX
NasdaqGS:EQIXSpecialized REITs

Is It Too Late To Consider Equinix (EQIX) After A 41% Year To Date Rally?

Investors may be wondering whether Equinix at around US$1,077 per share still offers value, or if most of the opportunity is already reflected in the price. The stock is up 41.0% year to date and 28.3% over the past year, even though it has slipped 1.0% over the last week and is up 1.9% over the past month. Recent coverage has focused on Equinix's position as a key player in data center and digital infrastructure, as investors weigh how demand for connectivity and cloud ecosystems feeds into...
NYSE:TDG
NYSE:TDGAerospace & Defense

Is It Time To Reassess TransDigm Group (TDG) After The Recent Share Price Pullback

This article looks at what the numbers indicate about whether TransDigm Group, at around US$1,201 per share, still offers value or whether most of the opportunity is already reflected in the price. The share price has fallen 2.6% over the last week and over the last 30 days, is down 11.6% year to date, and 7.7% over the past year, while the 3 year and 5 year returns stand at 71.4% and 146.0% respectively. Recent coverage of TransDigm Group has largely focused on its role within the broader...
NYSE:SUNB
NYSE:SUNBTrade Distributors

Sunbelt Rentals Holdings (SUNB) Valuation Check As US$1.5b Buyback Program Continues

Sunbelt Rentals Holdings buyback puts capital returns in focus Sunbelt Rentals Holdings (SUNB) recently repurchased 75,000 shares as part of its ongoing US$1.5b buyback program, a move that puts capital allocation and shareholder returns in the spotlight for investors. See our latest analysis for Sunbelt Rentals Holdings. At a share price of US$76.07, Sunbelt Rentals Holdings has logged a 1 month share price return of 9.86% and a year to date share price return of 14.25%. Its 1 year total...